Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4866955
Max Phase: Preclinical
Molecular Formula: C39H65N17O9
Molecular Weight: 916.06
Molecule Type: Unknown
Associated Items:
ID: ALA4866955
Max Phase: Preclinical
Molecular Formula: C39H65N17O9
Molecular Weight: 916.06
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(C)C[C@H](NC(=O)[C@@H]1CC(=O)NCC(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O
Standard InChI: InChI=1S/C39H65N17O9/c1-20(2)16-27(35(64)53-24(7-4-14-48-38(43)44)33(62)54-26(31(40)60)17-21-9-11-22(57)12-10-21)55-36(65)28-18-29(58)50-19-30(59)51-23(6-3-13-47-37(41)42)32(61)52-25(34(63)56-28)8-5-15-49-39(45)46/h9-12,20,23-28,57H,3-8,13-19H2,1-2H3,(H2,40,60)(H,50,58)(H,51,59)(H,52,61)(H,53,64)(H,54,62)(H,55,65)(H,56,63)(H4,41,42,47)(H4,43,44,48)(H4,45,46,49)/t23-,24+,25+,26+,27+,28+/m1/s1
Standard InChI Key: WJFJMZPLMDARIZ-JVACCQEYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 916.06 | Molecular Weight (Monoisotopic): 915.5151 | AlogP: -5.32 | #Rotatable Bonds: 23 |
Polar Surface Area: 452.72 | Molecular Species: BASE | HBA: 12 | HBD: 18 |
#RO5 Violations: 3 | HBA (Lipinski): 26 | HBD (Lipinski): 22 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 9.47 | CX Basic pKa: 12.08 | CX LogP: -7.32 | CX LogD: -12.85 |
Aromatic Rings: 1 | Heavy Atoms: 65 | QED Weighted: 0.03 | Np Likeness Score: 0.43 |
1. Konieczny A, Conrad M, Ertl FJ, Gleixner J, Gattor AO, Grätz L, Schmidt MF, Neu E, Horn AHC, Wifling D, Gmeiner P, Clark T, Sticht H, Keller M.. (2021) N-Terminus to Arginine Side-Chain Cyclization of Linear Peptidic Neuropeptide Y Y4 Receptor Ligands Results in Picomolar Binding Constants., 64 (22.0): [PMID:34748345] [10.1021/acs.jmedchem.1c01574] |
Source(1):